Farther Finance Advisors LLC Lowers Stock Holdings in Core Laboratories Inc. $CLB

Farther Finance Advisors LLC cut its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 83.8% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,869 shares of the oil and gas company’s stock after selling 19,997 shares during the quarter. Farther Finance Advisors LLC’s holdings in Core Laboratories were worth $45,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in CLB. Ariel Investments LLC raised its stake in Core Laboratories by 7.4% during the 1st quarter. Ariel Investments LLC now owns 10,342,025 shares of the oil and gas company’s stock valued at $155,027,000 after purchasing an additional 709,455 shares during the period. Fred Alger Management LLC grew its holdings in Core Laboratories by 32.4% during the 1st quarter. Fred Alger Management LLC now owns 736,853 shares of the oil and gas company’s stock valued at $11,045,000 after buying an additional 180,344 shares in the last quarter. Hotchkis & Wiley Capital Management LLC bought a new stake in shares of Core Laboratories during the first quarter valued at approximately $6,008,000. Envestnet Asset Management Inc. lifted its holdings in shares of Core Laboratories by 1.3% in the first quarter. Envestnet Asset Management Inc. now owns 254,005 shares of the oil and gas company’s stock worth $3,808,000 after buying an additional 3,357 shares in the last quarter. Finally, Advisors Capital Management LLC boosted its position in shares of Core Laboratories by 3.3% during the first quarter. Advisors Capital Management LLC now owns 238,867 shares of the oil and gas company’s stock worth $3,581,000 after acquiring an additional 7,718 shares during the last quarter. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CLB has been the topic of several research reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Core Laboratories in a report on Saturday, September 27th. Stifel Nicolaus reduced their price objective on Core Laboratories from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, July 26th. Finally, Zacks Research raised shares of Core Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, August 15th. Three investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average price target of $12.50.

Core Laboratories Stock Performance

Shares of NYSE:CLB opened at $12.36 on Tuesday. The company has a current ratio of 2.27, a quick ratio of 1.70 and a debt-to-equity ratio of 0.47. Core Laboratories Inc. has a 12 month low of $9.72 and a 12 month high of $21.83. The company has a market capitalization of $579.56 million, a price-to-earnings ratio of 19.94, a PEG ratio of 3.67 and a beta of 1.38. The firm’s 50-day moving average is $11.57 and its 200 day moving average is $11.97.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.01. The business had revenue of $130.16 million during the quarter, compared to the consensus estimate of $129.19 million. Core Laboratories had a net margin of 5.73% and a return on equity of 14.15%. The firm’s quarterly revenue was down .3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.22 earnings per share. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS. Research analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, August 25th. Shareholders of record on Monday, August 4th were paid a $0.01 dividend. The ex-dividend date was Monday, August 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. Core Laboratories’s dividend payout ratio (DPR) is presently 6.45%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.